Mark U Juul

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1

Top Topics

Mesenchymal Stem Cells

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sabine Zitzmann-Kolbe, Alexander Kristian, Dieter Zopf, Claudia Kamfenkel, Oliver Politz, Christine Ellingsen, Jochen Hilbig, Mark U Juul, Jesper Fonslet, Carsten H Nielsen, Christoph A Schatz, Roger M Bjerke, Alan S Cuthbertson, Dominik Mumberg, Urs B Hagemann
A targeted thorium-227 conjugate demonstrates efficacy in preclinical models of acquired drug resistance and combination potential with chemotherapeutics and antiangiogenic therapies. Molecular cancer therapeutics (2023)